MRC1 and neoplasm: Much like tumor-infiltrating lymphocytes (TILs), the numbers of tumor-infiltrated TAMs (F4/80+), and those of M1 (CD68+) and M2 (CD206+) macrophages, were slightly increased by docetaxel treatment but significantly increased by treatment with TH1902 (Figures 6A, B).